TRANSLATE BIO INC's ticker is TBIO and the CUSIP is 89374L104. A total of 151 filers reported holding TRANSLATE BIO INC in Q4 2020. The put-call ratio across all filers is 7.16 and the average weighting 0.2%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Advisors, Inc. | 3,922,008 | $39,102,000 | 52.94% |
| Omega Fund Management, LLC | 2,437,603 | $24,303,000 | 10.06% |
| Baupost Group | 17,544,239 | $171,071,000 | 2.52% |
| FRAZIER MANAGEMENT LLC | 2,182,789 | $21,762,000 | 2.47% |
| RTW INVESTMENTS, LP | 3,692,424 | $36,813,000 | 1.58% |
| Camber Capital Management LP | 1,765,000 | $17,597,000 | 1.05% |
| Bain Capital Public Equity Management II, LLC | 416,670 | $4,154,000 | 0.49% |
| Rock Springs Capital Management LP | 825,000 | $8,225,000 | 0.34% |
| Birchview Capital, LP | 30,000 | $299,000 | 0.26% |
| Artal Group S.A. | 600,000 | $5,982,000 | 0.25% |